Longitudinal MRI findings in pyridoxine-dependent seizures

Neurology

Volumn 51, Issue 1, 1998, Pages 74-78

  Gospe Jr , Sidney M ^a,b,c   Hecht, Stephen T ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LORAZEPAM; PHENOBARBITAL; PHENYTOIN; PYRIDOXINE;

ANTICONVULSANT THERAPY; ARTICLE; BRAIN SIZE; CASE REPORT; CHILDHOOD DISEASE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEIZURE;

EID: 0345404150     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.1.74     Document Type: Article

References (18)

1. Gospe SM. Current perspectives on pyridoxine-dependent seizures. J Pediatr 1998 (in press).
2. Hunt AD, Stokes J, McCrory WW, Stroud HH. Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics 1954;13:140-145.
3. Haenggeli C-A, Girardin E, Paunier L. Pyridoxine-dependent seizures, clinical and therapeutic aspects. Eur J Pediatr 1991; 150:452-455.
4. Goutières F, Aicardi J. Atypical presentations of pyridoxine-dependent seizures: a treatable cause of intractable epilepsy in infants. Ann Neurol 1985;17:117-120.
5. Coker S. Postneonatal vitamin B6-dependent epilepsy. Pediatrics 1992;90:221-223.
6. Tanaka R, Okumura M, Arima J, Yamakura S, Momoi T. Pyridoxine-dependent seizures: report of a case with atypical clinical features and abnormal MRI scans. J Child Neurol 1992;7:24-28.
7. Jardin LB, Pires RF, Martins CES, et al. Pyridoxine-dependent seizures associated with white matter abnormalities. Neuropediatrics 1994;25:259-261.
8. Shih JJ, Kornblum H, Shewmon DA. Global brain dysfunction in an infant with pyridoxine dependency: evaluation with EEG, evoked potentials, MRI, and PET. Neurology 1996;47: 824-826.
9. Baxter P, Griffiths P, Kelly T, Gardner-Medwin D. Pyridoxine-dependent seizures: demographic, clinical, MRI and psychometric features, and effect of dose on intelligence quotient. Dev Med Child Neurol 1996;38:998-1006.
10. Gospe SM, Olin KL, Keen CL. Reduced GABA synthesis in pyridoxine-dependent seizures. Lancet 1994;343:1133-1134.
11. Bekkelund SI, Pierre-Jerome C, Mellgren SI. Quantitative cerebral MRI in epileptic patients. Acta Neurol Scand 1996;94: 378-382.
12. Mikati MA, Trevathan E, Krishnamoorthy KS, Lombroso CT. Pyridoxine-dependent epilepsy: EEG investigations and long-term follow-up. Electroencephalogr Clin Neurophysiol 1991; 78:215-221.
13. Emery ES. Unusual case of pyridoxine-responsive seizures. Ann Neurol 1984;16:395. Abstract.
14. 6-dependent seizures: pathology and chemical findings in brain. Neurology 1978;28:47-54.
15. Tortori-Donati P, Fondelli MF, Rossi A, Carini S. Cystic malformations of the posterior cranial fossa originating from a defect of the posterior membranous area. Mega cisterna magna and persisting Blake's pouch: two separate entities. Childs Nerv Syst 1996;12:303-308.
16. Adam R, Greenberg JO. The mega cisterna magna. J Neurosurg 1978;48:190-192.
17. Baumeister FAM, Gsell W, Shin YS, Egger J. Glutamate in pyridoxine-dependent epilepsy: neurotoxic glutamate concentration in the cerebrospinal fluid and its normalization by pyridoxine. Pediatrics 1994;94:318-321.
18. Meldrum BS. Excitotoxicity and selective neuronal loss in epilepsy. Brain Pathol 1993;4:405-412.